Neurophet specializes in developing AI-powered software and platforms, offering a comprehensive portfolio that includes AI-based brain imaging analysis software and medical devices for neuromodulation. Our technologies allow clinicians to better understand brain structure and translate these insights into optimized therapeutic interventions.

Our neuromodulation portfolio is:

1. Neurophet tES LAB: A simulation software designed for planning transcranial electrical stimulation (tES). It utilizes Neurophet's AI technology to perform brain segmentation, visualize electric fields, and design patient-specific stimulation protocols.
2. Neurophet innk: A proprietary, compact tDCS device engineered to deliver these precise treatments effectively.

In Korea, the combination of tES LAB and innk has been officially designated as an Innovative Health Technology under the category of "Artificial Intelligence-based Customized Transcranial Direct Current Stimulation using MR Images." Specifically approved for the purpose of improving finger motor function in stroke patients with paralysis, it currently stands as the only tDCS solution available for rehabilitation therapy in Korea (as of Dec 2025).

https://www.neurophet.com/en